We good double and market cap STILL ONLY $100 MILLION
For a company with a phase II, CANCER freaking drug showing high efficacy and low incidents of side effects and test potential for numerous other cancers AND the agri-animal markets? There are a HUNDRED bio-techs trading this second- with market caps of $200 to $300 million that don't have JACK going for them- nothing tangible at this stage. Big pharma has REGULARLY been making acquisitions in the $1 BILLION or so range without even batting an eye brow- it's "funny money" to them - as they MUST keep their pipelines full and only need a SINGLE blockbuster drug every 5 to 10 yrs or so to be king of the pharma field. You get yourself ONE winning cancer drug, or ONE "lipitor" or ONE viagra or ONE prozac- and you will make so freaking much money- it funds your company operations for the next 10 yrs. Simple as that. This drug ADXS and it's core technology- is one of the most exciting cancer fighting concepts/drugs I've read of in the past 10 yrs. You have a significant number of trial candidates who have gone from unmitigated, no hope, DEATHS DOOR- into full remission per PUBLIC STATEMENTS by ADXS. They can't make those statements w/o risking the SEC PERP WALK unless they are certain their science is solid and the results are 100% true. This is AMAZING, potentially new paradigm altering stuff we're talking about. Hold on tight- this could get real exciting. If you want- set a "loose" stop as it moves up, say at 0.10 now and "walk it up" as it moves up. I wouldn't use a tight stop right now- as the MM's need inventory to fill this vol and rapidly moving share price- and they will clean out "tight" stops on a daily basis as needed. MY 2 cents.
Don't forget, the MMs can and do blow by ALL kinds of stops or buy orders, sell orders, etc. as they see fit. The SEC is not much of a watch dog, maybe lapdog is a better word. I am not diasgreeing with you, just saying I have seen them blown through too many times, and they know WE will not sue or even complain. To who?